Cold agglutinin disease revisited: a multinational, observational study of 232 patients
Sigbjørn Berentsen(Privatsykehuset Haugesund), Geir E. Tjønnfjord(Oslo University Hospital), Markku Oksman(Turku University Hospital), Agnieszka Małecka(Oslo University Hospital), Eirik Tjønnfjord(Østfold Hospital Trust), Shirley D’Sa(University College Hospital), Jakob Dalgaard(Drammen Hospital), Pernille H. Jæger(St Olav's University Hospital), Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Robert Brudevold(Ålesund Hospital), Megan Kell(University College London Hospitals NHS Foundation Trust), Ulla Randen(Akershus University Hospital), Tor Henrik Anderson Tvedt(Haukeland University Hospital), Hege Frøen(Vestre Viken Hospital Trust), Galina Tsykunova(Haukeland University Hospital), Jürgen Rolke(Sørlandet Sykehus), Henrik Hjorth‐Hansen(Norwegian University of Science and Technology), Jon Hjalmar Sørbø(Levanger Hospital), Einar Haukås(Stavanger University Hospital), Mallika Sekhar(Royal Free London NHS Foundation Trust), Anders Erik Astrup Dahm(University of Oslo), Bruno Fattizzo(University of Milan), Randi Fykse Hallstensen(Nordland Hospital)
Cited by 167
Related Papers
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
|Blood|2014|371
Guidelines for the diagnosis and management of multiple myeloma 2011
|British Journal of Haematology|2011|305